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Abstract
Background: In the last few years, there has been an increasing interest in the use of robotic devices to objectively
quantify motor performance of patients after brain damage. Although these robot-derived measures can potentially
add meaningful information about the patient’s dexterity, as well as be used as outcome measurements after the
rehabilitation treatment, they need to be validated before being used in clinical practice. The present work aims to
evaluate the reliability, the validity and the discriminant ability of the metrics provided by a novel robotic device for
upper limb rehabilitation.
Methods: Forty-eight patients with sub-acute stroke and 40 age-matched healthy subjects were involved in this
study. Clinical evaluation included: Fugl-Meyer Assessment for the upper limb, Action Research Arm Test, and
Barthel Index. Robotic evaluation of the upper limb performance consisted of 14 measures of motor ability
quantifying the dexterity in performing planar reaching movements. Patients were evaluated twice, one day apart,
to assess the reliability of the robotic metrics, using the Intraclass Correlation Coefficient. Validity was assessed by
analyzing the correlation of the robotic metrics with the clinical scales, by means of the Spearman’s Correlation
Coefficient. Finally, the ability of the robotic metrics to distinguish between patients with stroke and healthy
subjects was investigated with t-tests and the Effect Size.
Results: Reliability was found to be excellent for 12 measures and from moderate to good for the remaining 2.
Most of the robotic indices were strongly correlated with the clinical scales, while a few showed a moderate
correlation and only one was not correlated with the Barthel Index and weakly correlated with the remain two.
Finally, all but one the provided metrics were able to discriminate between the two groups, with large effect sizes
for most of them.
Conclusion: We found that all the robotic indices except one provided by a novel robotic device for upper limb
rehabilitation are reliable, sensitive and strongly correlated both with motor and disability clinical scales. Therefore,
this device is suitable as evaluation tool for the upper limb motor performance of patients with sub-acute stroke in
clinical practice.
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Background
In the last years, Robot – Mediated Therapy has repre-
sented one of the most promising approach to restore
motor function of upper limb after brain damage [1]
mainly because it enables, in comparison with conven-
tional treatment approaches, highly intensive trainings in
specifically designed tasks, for extended periods of time
[2]. Along with their use as rehabilitation tools, the
robotic devices can also act as evaluation tools in order
to objectively quantify motor performance of patients
after brain damage. In fact, because of their built-in
technology in terms of sensors and actuators, the robotic
devices are able to acquire data about kinematics and
kinetics of patients’ upper limb which are processed to
obtain quantitative indices related to the upper-
extremity movement quality. According to Sivan et al.
[3], these robotic indices are appropriate as a tool to
describe bodily functions on all phases of stroke recov-
ery and, therefore, can be effectively used to assess both
the level of impairment as well as the improvement after
therapy. Robotic indices are therefore increasingly used
to assess patients’ dexterity (where loss of dexterity re-
fers to an inability to coordinate muscle activity in the
performance of a motor task [4]) with the aim of
overcoming, at least partially, the intrinsic limitations
of the clinical scale, such as a low rate of reproduci-
bility, low resolution, lack of sensitivity, as well as
floor and ceiling effects [5].
Even though most of the studies involve patients with
stroke [6–14], robotic evaluations are also used in
neurological diseases as Multiple Sclerosis [15], Cerebral
Palsy [16, 17], or Ataxia [18].
On their review, Nordin et al. [19] identified more
than fifty different kinematic metrics currently used in
robot-assisted rehabilitation researches. Usually, the
evaluated movement is a reaching task, and more specif-
ically center-out point-to-point movement, since it is
important to perform in many activities of daily life. Less
often, different tasks, such as shape drawing/tracing
tasks, are also analyzed.
Although these new robot-derived measures can po-
tentially add meaningful information about the patient’s
performance, their properties in terms of reliability, val-
idity and responsiveness should be assessed, before their
use in clinical practice. In fact, in order to be brought
into the clinical field, they have to be stable, sensitive
and clinically meaningful measures. The review of
Maciejasz et al. [20] identified more than 120 robotic
devices for upper limb rehabilitation and most of them
allow measuring kinematic and/or kinetic parameters
which describe the motor ability of patients. If one con-
siders the amount of robots for the upper limb that are
currently available, few studies have investigated the psy-
chometric properties of the robotic indices [7, 18, 21]
and, except for a few cases, a complete analysis of their
metric characteristics and concurrent validity with clin-
ical scales is missing [19]. In addition, it is mandatory to
validate the metrics provided by the specific device of
interest. In fact, the robotic structure and the provided
support can be different among devices, affecting the
validity and sensitivity of the results [7]. As suggested by
Nordin et al. [19], the mechanical structure of the robot,
as well as its control scheme, play an important role in
providing assessment data. As an example, data obtained
from end-effector robots cannot be directly compared
with those provided by exoskeletons, since the degree of
interaction between patients and robot is different in
terms of support and mechanical interface and this
could affect the patient’s performance. The results
obtained with a specific device cannot be arbitrarily
extended to a different one, since they likely have a
different conception. Therefore, for each device it is
necessary to verify the validity and sensitivity of the
instrumental outcome measures.
Recently, a novel type of haptic interface was
proposed, which is fully portable and employs onboard
sensors and electronics to solve accurate localization
and also uses motors for force feedback generation [22].
This end-effector device has been designed for applica-
tion in neuro-rehabilitation protocols and it adopts
specific mechanical, electrical and control solutions in
order to cope with patient requirements. Along with
several therapeutic scenarios, it also qualifies as an
evaluation tool providing some indices about the
patients’ sensor-motor skills, similar to those already
described in literature.
To the best of our knowledge, however, the quantita-
tive indices provided by this device have not yet been
validated in terms of their psychometric properties.
Therefore, the goal of the present work is to evaluate,
within a multicenter study aimed to compare a trad-
itional and a robotic rehabilitation approach, the reliabil-
ity, the concurrent validity and the discriminant ability
of the indices provided by a novel rehabilitation device
during an unassisted reaching task.
Methods
Participants
Forty-eight consecutive patients with subacute stroke
(both inpatient and outpatients) were enrolled in 4 dif-
ferent rehabilitation centers of the Fondazione Don
Carlo Gnocchi for this study. Inclusion criteria were: (1)
first-ever stroke (cerebral infarction or hemorrhage),
confirmed by either brain CT or MRI findings (2) age
between 40 and 85 years; (3) time latency since stroke
ranging from 2 weeks to 6 months; (4) cognitive and
language abilities sufficient to understand the experi-
ments and follow instructions. Exclusion criteria were:
Germanotta et al. Journal of NeuroEngineering and Rehabilitation  (2018) 15:39 Page 2 of 14
(1) upper extremity Fugl-Meyer score > 58; (2) behavioral
and cognitive disorders and/or reduced compliance that
would interfere with active therapy; (3) fixed contraction
deformity in the affected limb that would interfere with
active therapy (ankylosis, Modified Ashworth Scale = 4);
(4) inability to discriminate distinctly the images showed
on a 22″ monitor placed at the eye level of each subject
at a distance of about 50 cm, even with corrective
glasses. Forty age-matched subjects without neurological
or other relevant medical conditions served as a refer-
ence population. Demographic and characteristics of the
participants are shown in Table 1.
This study is a cross-sectional objective analysis of base-
line data collected as part of a larger clinical trial, ap-
proved by the institutional ethics committee (FDG_6.4.
2016) and registered at clinicaltrials.gov with identifier
number (NCT02879279). All participants gave informed
consent according to the Declaration of Helsinki.
Clinical assessment
Patients were clinically evaluated using the upper limb
part Fugl-Meyer Assessment of Motor Recovery after
Stroke (FMA), the Action Research Arm test (ARAT)
and the Barthel Index (BI).
The FMA evaluates recovery in post-stroke hemiplegic
patients and it is one of the most widely used quantita-
tive measures of motor impairment [23]. It is character-
ized by a high inter-rater reliability [24, 25] and validity
[26]. This measure includes five domains (motor func-
tion, sensory function, balance, joint range of motion,
joint pain) to assess synergistic and voluntary movement
after stroke. A three-point ordinary scale is used to
assess movement (0 = unable; 1 = partial; 2 = performs
fully) in each item. In this research we used the upper
limb section in the motor function domain (FMA-UL).
The score ranges from 0 (most severe impairment) to 66
(no impairment).
The ARAT [27] assesses upper limb function using ob-
servational methods and consists of 19 items organized
in 4 sections: Grasp, Grip, Pinch and Gross movements.
The performance of each task is scored on a 4-point
ordinal scale (0 = unable to complete any part of the
task, 1 = the task is only partially completed, 2 = the task
is completed but with great difficulty and/or in an
abnormally long time, and 3 = the movement is per-
formed normally). The maximum ARAT score is 57
points, which means normal upper limb function.
The BI [28] assesses the ability of an individual with a
neuromuscular or musculoskeletal disorder to take care of
him/herself, and consists of 10 items, evaluating both
personal care (feeding, dressing, hygiene) and mobility ac-
tivities (transferring, walking/wheeling). Possible values
range from 0 to 100, with lower scores representing
greater dependency.
Equipment and robotic assessment
The robotic assessment of upper limb motor perform-
ance was conducted by means of MOTORE (MObile
roboT for upper limb neurOrtho Rehabilitation, Human-
ware, Italy), see Fig. 1. This is a planar end-effector
device designed for application in neuro-rehabilitation
protocols and it adopts specific mechanical, electrical
and control solutions in order to meet the requirements
of neuro-rehabilitation. MOTORE is equipped with an
onboard computing unit, an odometry system (based on
encoders) and a specifically designed global localization
system (which recognizes patterns on the working sur-
face). In fact, the device moves by means of transwheels
on the planar working surface and it uses a 2DOF load
cell in the handle to measure the interaction force with
the patient. The device has 3 DC motors so that it can
(a) help the patient when he/she is not able to
Table 1 Demographic and clinical characteristics of the sample
Patients with
stroke (n = 48)
Healthy
subjects (n = 40)
Sex M/F 33/15 26/14
Age, mean ± SD (years) 64 ± 11 65 ± 13
Classification
Cerebral ischemia (N) 28 –
Cerebral hemorrhage (N) 20 –
Time from lesion, mean ± SD (days) 88 ± 42 –
FMA-UL, mean ± SD 29 ± 18 –
ARAT, mean ± SD 15 ± 18 –
BI, mean ± SD 40 ± 24 –
SD Standard Deviation, FMA-UL Fugl-Meyer Assessment for the Upper Limb,
ARAT Action Research Arm Test, BI Barthel Index
Fig. 1 Patient engaged in a rehabilitation session with MOTORE
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accomplish the task, (b) prevent movements different
from the ideal trajectories, (c) provide different weight
and viscosity behaviors, (d) maintain a proper orienta-
tion on the plane. The device generates force feedback
without any intermediate link to the ground or frame,
thanks to the motion of the wheels and using the infor-
mation obtained from the load cell. A Bluetooth connec-
tion links the device to a PC unit, where a software
shows targets to be reached and trajectories to be
followed as well as a user/therapist interface for the se-
lection of the exercise parameters. The robot is con-
trolled in admittance mode: forces measured by the load
cell are used to determine the linear velocity of the de-
vice, on the basis of two parameters (M, that is the ap-
parent mass of the device, and b, that is the nominal
viscosity) that can be modified to change the robot be-
havior [29]. Compared with other similar robotic sys-
tems, it is characterized by its portability, being
specifically conceived for teleoperation applications.
During the rehabilitation session, ambulatory subjects
are comfortably seated on a chair, while non-ambulatory
patients are seated on their wheelchair, in front of a
height-adjustable table. The center of the workspace is
located in front of the subject at the midline of the body.
Subject’s forearm is supported by the device, with his/
her hand grasping the handle of the robot.
Similar to other devices, together with several rehabili-
tation exercises (based both on tracking or occupational-
like exercises) it provides an Evaluation Task, based on a
center-out point-to-point reaching activity: following a
visual feedback, subjects are asked to move the device
from the center to a peripheral target and come back to
the center, starting at the “East” position and proceeding
clockwise, making a total of 16 reaching movements.
During the Evaluation Task, both the position of the
robot (a white ball) and of the target to be reached (a
yellow circle) are shown on the screen. The provided vis-
ual feedback, the target location and the movement se-
quence are shown in Fig. 2. Once the test is completed,
several indices are computed by the device and displayed
to give a feedback to the patient about her/his perform-
ance. These indices are summarized in Table 2. During
the Evaluation Task, the apparent mass M and nominal
viscosity b are set to the minimum, to minimizing the
inertia of the device and, therefore, to allow the patient
to move it with the least possible effort.
Experimental protocol
In our study, each participant was asked to perform the
Evaluation Task provided by the device three times,
making a total of 48 reaching movements (i.e., three
nonconsecutive reaching movements for each direction).
The participants were not asked to perform the task
with a specific time constraint and, then, the movement
accuracy was implicitly a task requisite [18, 30]. When a
patient or a healthy subject was unable to reach a target
(due to the upper limb impairment, or to the wide
investigated workspace), he/she was asked to move
the robot as far as possible toward the target. For
each subject, a session (three repetitions of the Evalu-
ation Task) lasted between 5 and 10 min, depending
on the patient’s impairment.
All the patients and a subgroup of healthy subjects
were tested twice, 1 day apart, to assess the test-retest
reliability of the provided outcome measures. For both
test sessions, the value of each metric obtained in the
three repetition was recorded and their mean value was
computed and used for the statistical analysis.
Fig. 2 The evaluation task of MOTORE. In figure is showed the visual
feedback showed to the patients on the screen, together with the
position of each target. The white ball indicates the position of the
end-effector; the yellow circle indicates the target to be reached.
The yellow squares, not showed to the patient during the task,
indicate the position of the targets: C is the central target, while
the numbers from 1 to 8 indicate the external targets with the
sequence of the center-out movements. In addition, the distance
of each target from the center is reported
Table 2 Outcome measures provided by MOTORE
Index Description
Duration Time required to complete the task
Velocitymean Average velocity of the device during the test
Lengthtot Global length of the path travelled by the subject during
center-out movements; it ranges from 0 (no movement)
to 2.808 m (patient can fully perform the entire task)
Lengthi Length of the path travelled by the subject toward
the i-th target (i = 1:8)
Score Mean of the ratios between the actual distance covered
by the patients and the required distance to be travelled,
computed for each required movement.
It ranges from 0 (no movement) to 10 (the patient can
fully perform the required task)
Worktot Line integral of the force along the path described by
the patient
Worktan The amount of total work directed towards the target
Germanotta et al. Journal of NeuroEngineering and Rehabilitation  (2018) 15:39 Page 4 of 14
Statistical analysis
All statistical analyses were performed using MedCalc
(version 17, MedCalc Software, Ostend, Belgium) and
SPSS (version 20, SPSS Inc., Chicago IL, USA).
Test-retest reliability
Relative test-retest reliability was assessed based on data
obtained from patients at the two test sessions by using
the Intraclass Correlation Coefficient (ICC), using a two-
way random effect, absolute agreement, multiple mea-
surements model. Reliability was classified as excellent
(ICC > 0.90), good (0.75 < ICC ≤ 0.90), moderate (0.5 <
ICC ≤ 0.75) or poor otherwise [31]. Absolute test-retest
reliability was analyzed comparing for each index data
obtained during the two test sessions by mean of paired
t-tests and Bland-Altman plots.
Intra-session reliability was investigated in stroke
patients comparing the data obtained in the three repeti-
tions, for each session separately, by using a repeated
measure ANOVA test. For each index, if the test was
significant, a post-hoc analysis with Bonferroni correc-
tion was carried out.
Concurrent validity
To assess the concurrent validity of the robotic indices,
the correlations between the robotic parameters and the
clinical scales (FMA-UL and ARAT) were investigated
using the Spearman’s rank correlation coefficients. The
same analysis was used to investigate the relationships
between robotic indices and impairment in the activities
of daily living, as measured by the BI. The coefficient
values were interpreted as follows [32]: 0.0–0.2 little if
any; 0.2–0.4 weak; 0.4–0.7 moderate; 0.7–1.0 strong.
Discriminant ability
The ability of the robotic indices to discriminate stroke
patients from healthy subjects was evaluated by means
of unpaired t tests; for each index, the effect size was
also evaluated through the Cohen’s d coefficient (small
≥0.20, medium ≥0.50, large ≥0.80 [33]).




ICCs and 95% confidence intervals, as well as the results
of the statistical analysis of the comparison of the two
assessments, are shown in Table 3.
Referring to the relative test-retest reliability, Duration,
Velocitymean, Lengthtot, Length1, Length4, Length5,
Length6, Length7, Length8, Score, Worktot and Worktan
displayed an excellent reliability (ICC > 0.9), while a good
(ICC ≥ 0.75) and a moderate (ICC ≥ 0.5) reliability was
shown by Length2 and Length3 respectively. With
respect to the absolute reliability, we found a statistically
significant reduction of Duration (p = 0.004) and a statis-
tically significant increase of Velocitymean (p < 0.001),
when data obtained at the first test session were com-
pared with those obtained 1 day after (see Figs. 3 and 4
for Bland-Altman analysis).
Finally, the intra-session reliability showed, during the
test, a significant decrease of the Duration (p = 0.05),
and a significant increase of the Velocitymean (p < 0.001)
and the Score (p = 0.045), while, during the retest, only a
significant increase of the Velocitymean was found (p = 0.
001). With respect all the remaining indices, no differ-
ences between repetitions were found (see Figs. 5 and 6).
With respect to the healthy subjects, we found that
the relative test-retest reliability was excellent for the
Duration, good for the Velocitymean and the Worktan,
and moderate to poor for all the remaining indices
(Table 4). The absolute reliability showed that a signifi-
cant decrease of the Duration (p < 0.001) and a signifi-
cant increase of the Velocitymean (p = 0.014) and the
Worktan (p = 0.04).
Concurrent validity
The results of the correlation analysis between the ro-
botic indices and the clinical scale are shown in Table 5.
Most of the robotic indices showed a strong correlation
with the FM, with Length2 e Length3 being moderately
correlated and Worktot weakly correlated with the FM.
When examining correlations between robotic indices
and the ARAT, we observed similar results to those
obtained with the FM, with slightly lower correlation
coefficients overall. Finally, all the provided indices but
the Worktot were moderately correlated (11 indices) to
strongly correlated (2 indices, namely Lengthtot and Score)
with the BI. It is worthy to note that almost all the correla-
tions are significant wit a p level lower than 0.001 and,
therefore, they remain significant even after a Bonferroni
correction (i.e., with an alpha set to 0.05/42 = 0.0012,
where 42 is the number of analyzed correlations). The re-
sults of the correlation analysis between the robotic indi-
ces are provided as Additional file 1: Table S1.
Discriminant ability
The expected ability of the robotic indices to distinguish
between patients with subacute stroke and age-matched
healthy subjects was confirmed by the results of the stat-
istical analysis. In fact, all the robotic indices but the
Worktot obtained from patients with sub-acute stroke
were statistically different from those of controls (see
Table 6). The analysis of the effect size showed that the
discriminant ability was medium for the Worktan and
large for all the remaining indices, being ES higher than
1 for 8 of them.
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Discussion
In this study we assessed for the first time the intra-
session and the between-day test-retest reliability, and
the validity of the outcome measures provided by a
novel planar robot for upper limb rehabilitation, in a
sample of patients with sub-acute stroke, and their
ability to differentiate patients from a group of age-
matched healthy subjects. The abovementioned outcome
measures assess the ability of patients in performing a
planar reaching task. Similar protocols are provided by
several robotic devices and extensively used to assess the
residual motor ability of the upper limb in patients with
stroke [6–14], or other neurological diseases [15, 16, 34].
However, the specific mechanical, electrical and control
solutions adopted in the device requires a validation of
the provided measures, since the results obtained from
different devices cannot be simply extended [7]. In fact,
because each robot differ from the others in terms of





ICC 95% CI Paired t
test (P)Lower bound Upper bound
Duration (s) 193.7 (107.30) 176.8 (111.90) 0.962 0.922 0.980 0.004
Velocitymean (m/s) 0.05 (0.04) 0.07 (0.04) 0.914 0.756 0.962 < 0.001
Lengthtot (m) 1.80 (0.92) 1.84 (1.01) 0.951 0.912 0.972 0.495
Lenght1 (m) 0.25 (0.16) 0.25 (0.18) 0.930 0.876 0.960 0.784
Lenght2 (m) 0.38 (0.14) 0.35 (0.17) 0.804 0.652 0.890 0.149
Lenght3 (m) 0.13 (0.03) 0.13 (0.02) 0.693 0.456 0.828 0.542
Lenght4 (m) 0.34 (0.18) 0.36 (0.17) 0.917 0.851 0.953 0.113
Lenght5 (m) 0.24 (0.17) 0.25 (0.18) 0.907 0.834 0.948 0.551
Lenght6 (m) 0.20 (0.17) 0.22 (0.18) 0.917 0.852 0.953 0.13
Lenght7 (m) 0.05 (0.04) 0.06 (0.04) 0.957 0.924 0.976 0.188
Lenght8 (m) 0.21 (0.17) 0.22 (0.18) 0.934 0.883 0.963 0.467
Score 7.91 (2.20) 7.99 (2.45) 0.972 0.949 0.984 0.477
Worktot (J) 19.88 (12.75) 20.79 (15.45) 0.908 0.837 0.949 0.446
Worktan (J) 10.22 (8.65) 11.26 (0.18) 0.957 0.922 0.976 0.061
Intraclass Correlation Coefficient (ICC) with 95% Confidence Interval (CI), and result of the t tests. Bold values indicated statistical significance, with p value less
than 0.05





ICC 95% CI Paired
t test
(P)
Lower bound Upper bound
Duration (s) 107.3 (56.30) 83.96 (50.02) 0.914 0.336 0.977 0.000
Velocitymean (m/s) 0.08 (0.04) 0.10 (0.06) 0.81 0.437 0.931 0.014
Lengthtot (m) 2.64 (0.29) 2.68 (0.21) 0.593 −0.064 0.844 0.484
Lenght1 (m) 0.39 (0.03) 0.39 (0.03) 0.627 −0.002 0.858 0.966
Lenght2 (m) 0.46 (0.08) 0.47 (0.09) 0.93 0.822 0.973 0.309
Lenght3 (m) 0.14 (0.01) 0.14 (0.00) § § § 0.331
Lenght4 (m) 0.46 (0.10) 0.48 (0.01) 0.01 −1.511 0.615 0.273
Lenght5 (m) 0.38 (0.06) 0.39 (0.03) 0.087 −1.446 0.652 0.458
Lenght6 (m) 0.35 (0.07) 0.35 (0.09) 0.722 0.260 0.894 0.870
Lenght7 (m) 0.09 (0.01) 0.09 (0.00) § § § 0.358
Lenght8 (m) 0.38 (0.04) 0.38 (0.06) 0.814 0.512 0.929 0.729
Score 9.68 (0.58) 9.78 (0.37) 0.522 −0.249 0.816 0.453
Worktot (J) 17.62 (10.29) 19.84 (8.21) 0.695 0.227 0.882 0.296
Worktan (J) 13.17 (7.38) 15.42 (6.61) 0.868 0.632 0.950 0.040
Intraclass Correlation Coefficient (ICC) with 95% Confidence Interval (CI), and result of the t tests. Bold values indicated statistical significance, with p value less
than 0.05. The symbol § indicate null variance in the data
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provided support, mechanical structure and control
algorithm, the validity and the sensitivity of similar
metrics could be different among different devices [7].
Differently from clinical scales, that are worldwide rec-
ognized and easy to administered in any rehabilitation
center, robotic outcome measures can be used only in
center equipped with similar devices, and the obtained
results are hard to share among centers. However, the
metrological characteristic of these measures are often
superior to those of clinical scales and, therefore, they
can be a very powerful tool to monitor the improvement
of the patients, at least in centers where similar devices
are installed. Moreover, the increasing data sharing
capacity, as well as the spread of these devices, may im-
prove in the future diffusion and use of these data
among centers.
With respect to the relative reliability, as assessed by
the ICCs, we found that almost all the provided indices
exhibited good to excellent reliability across the two sep-
arate testing days, in patients with sub-acute stroke.
These results are in accordance with previous works,
where a high reliability was shown by similar indices
provided by other upper limb robotic devices [8, 13, 35]
in stroke patients. It is worth noting that several indices
showed an ICC value higher than 0.9, meaning that
they could be used for intra-individual comparisons
(i.e. for individual decision-making) and not just for
group-level comparisons (i.e. for the evaluation of a
whole large group of patients), where an ICC value of
0.7 level is acceptable.
With respect to the absolute reliability, an unexpected
result was the significant decrease of the duration and
the significant increase of the Velocitymean in the second
evaluation (retest), when compared with the first (test).
It is likely that in the first test session patients were
more cautious in performing the required task, moving
Fig. 3 Bland-Altman plots of the robotic indices assessing the whole task
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the robot in a slower way, if compared to the second test
session. These results would have probably been differ-
ent if patients had performed a practice test before the
first evaluation, in order to familiarize with the device.
In fact, it must be highlighted that we have deliberately
chosen not to perform a practice test before the first
evaluation. Analyzing the data coming from each
repetition in the first day of evaluation, we found a sig-
nificant trend in both indices that, in the second day was
absent for the Duration and less evident for the Velocity-
mean. Therefore, our results support the hypothesis that,
at least with respect to these two indices (Duration and
Velocitymean), in clinical practice as well as in research
study, some familiarization trials, before the actual
Fig. 4 Bland-Altman plots of the robotic indices assessing the path length travelled by stroke patients towards each target
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evaluation, should be performed. This is particularly true
because both Duration and Velocitymean are hallmarks of
the upper limb impairment following a stroke [36] and
they have to be evaluated in a robotic assessment.
On the contrary, no other indices showed significant
differences in the two evaluations confirming their abso-
lute reliability, meaning that patients did not change the
travelled path or the mechanical work produced to move
the hand/robot.
With respect to the healthy subjects, similar or slightly
lower ICC values were found for the indices independent
from the travelled distance (i.e., the Duration, the Veloci-
tymean and the Worktan), while we obtained very low ICC
values for almost all the metrics related to the travelled
distance. This can be easily explained with the very low
to null between-subject variance in the data. Similar to
the stroke patients, a learning effect was detected, as
showed by the statistical significant differences in
Duration, Velocitymean and Worktan between the two
evaluations.
The validity study showed that all investigated indices
were significantly correlated with the Fugl-Meyer assess-
ment and the Action Research Arm Test. This led us to
confirm the concurrent validity of the robotic indices
against common clinical scale of upper limb impairment,
implying that they provide meaningful information from
a clinical point of view. Compared to the clinical scales,
the robotic assessment can be obtained quickly and
recorded at several time-points during the rehabilitation
path. The relation between the FM and the robotic
Fig. 5 Intra-session reliability analysis in stroke patients: robotic indices assessing the whole task. Blue lines represent the statistical analysis
of the first session (test), while green lines represent the statistical analysis of the second session (retest). The symbols *, ** and ***
represent a statistically significant difference between repetitions, with a p value less than 0.05, 0.01 and 0.001, respectively
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assessment has been largely studied, being the FM the
most commonly used clinical scale used in trial involving
robotic devices [3]. Generally, the robotic indices were
found to be correlated with the FM with similar or lower
correlation coefficient [5, 7, 10, 11, 21, 37–39], when
compared with those obtained with MOTORE. Similar
results were found in the correlation with the ARAT.
This result is not surprising, since the FM and the
ARAT were found to be highly correlated to each other
[40, 41]. The correlation coefficients we found were
Fig. 6 Intra-session reliability analysis in stroke patients: robotic indices assessing the path length travelled towards each target. Blue lines
represent the statistical analysis of the first session (test), while green lines represent the statistical analysis of the second session (retest)
Germanotta et al. Journal of NeuroEngineering and Rehabilitation  (2018) 15:39 Page 10 of 14
generally higher, when compared to other studies [42]. A
possible explanation could be the greater variability in
patient’s disability in our study, when compared to that
of other studies (see, for example, [7, 12, 37]). In fact, it
is known that the value of the correlation coefficient is
greater if there is more variability among the observa-
tions [43]. Of particular interest is the result about the
correlation between the robotic measures and the BI, be-
ing the BI a global measure of disability rather than a
motor assessment scale. This means that the upper limb
motor performance, even if measured in a simple planar
reaching task but in instrumental way, could, at least
partially, reflect the ability in the activities of daily living.
The differences we have found between the different
directions in terms of validity can be related to the
different level of difficulty of the required movement. In
fact, higher correlation coefficients were found for the
movements towards the targets farther from the subject’s
body (i.e., 6, 7 and 8), while lower coefficients were
found for the movements towards the targets nearer the
subject’s body (i.e., 2, 3 and 4). These differences can be
explained by considering some clinical aspects about the
upper limb motor recovery in patients with stroke. In
most cases, stroke patients are facilitated to perform
flexion elbow movements and, therefore, to lead their
arm toward the body. In other words, harder movements
can better differentiate the level of impairment of patient
and, therefore, can show higher correlations with the
clinical scales. With respect to the ICC analysis, the
lower value we found for the Length3 can be mainly
related to the lower variance between patients. Referring
to the discriminant ability, it should be underlined that
all the robotic indices but the Worktot were significantly
different between patients with sub-acute stroke and
healthy subjects, with a strong effect size (a moderate ef-
fect size was observed only for Worktan). With respect
to the Duration, our results are in accordance to those
obtained, for example, by Otaka et al. [7], or Coderre et
al. [13], where higher time necessary to complete planar
task were detected in patients with stroke, when com-
pared to healthy subjects. Similarly, with respect to the
Velocitymean, a reduction of speed in patients with stroke
was detected in several studies [6, 12].
Table 5 Validity
FMA-UL ARAT BI


























Spearman’s correlation coefficient between the robotic indices and the
following clinical scale: Upper limb subscale of the Fugl-Meyer Assessment
(FMA-UL), Action Research Arm Test (ARAT), and Barthel Index (BI). The symbols
**, and *** indicate a p value less than 0.01 and 0.001 respectively
Table 6 Discriminant ability
Robotic indices Patients with stroke (N = 48) Mean (SD) Healthy subjects (N = 40) Mean (SD) Unpaired t test (P) Effect Size
Duration (s) 193.7 (107.30) 93.30 (53.50) < 0.001 1.18
Velocitymean (m/s) 0.05 (0.04) 0.09 (0.05) < 0.001 0.86
Lengthtot (m) 1.80 (0.92) 2.67 (0.24) < 0.001 1.30
Lenght1 (m) 0.25 (0.16) 0.39 (0.03) < 0.001 1.17
Lenght2 (m) 0.38 (0.14) 0.46 (0.08) 0.001 0.75
Lenght3 (m) 0.13 (0.03) 0.14 (0.01) 0.004 0.62
Lenght4 (m) 0.34 (0.18) 0.47 (0.07) < 0.001 0.98
Lenght5 (m) 0.24 (0.17) 0.39 (0.04) < 0.001 1.20
Lenght6 (m) 0.20 (0.17) 0.35 (0.08) < 0.001 1.17
Lenght7 (m) 0.05 (0.04) 0.09 (0.00) < 0.001 1.31
Lenght8 (m) 0.21 (0.17) 0.38 (0.05) < 0.001 1.33
Score 7.91 (2.20) 9.74 (0.47) < 0.001 1.16
Worktot (J) 19.88 (12.75) 19.03 (9.11) 0.717 –
Worktan (J) 10.22 (8.65) 14.62 (6.98) 0.010 0.56
Descriptive statistics for the robotic indices in patients with stroke (N = 48) and healthy subjects (N = 40). Comparison is assessed by means of t tests. For
significant differences, the Effect Size is also reported
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A statistically significant difference between the two
groups was also found for all the Length and Score pa-
rameters, that are related to the ability of the patients to
travel the distance toward the target with the impaired
arm. Usually these parameters are not assessed in point-
to-point reaching tasks performed in a transversal plan,
since the patient’s ability to reach the target is a
mandatory requirement to be included in the evaluation
(see, for example, Otaka et al. [7]). However, a decreased
movement distance in reaching task is evident in
patients with stroke [44] and, therefore, in our opinion,
an evaluation of this aspect could add meaningful
information about the patient’s dexterity and the course
of the therapy.
Finally, referring to the work-related parameters, to
the best of our knowledge, ours is the first study that
evaluates the differences between patients with stroke
and healthy subject with similar metrics. We found that
Worktan was significantly different between the two
groups, while the Worktot was not. Zollo et al. [12]
employed both total and useful work (similar to the
Worktan), to assess the effect of the rehabilitation inter-
vention, rather than the motor skills of patients with
stroke. Interestingly, Zollo et al. found that the total
work did not change after therapy while the useful work
increased after the robotic treatment. Their results,
along with us, suggest to employ only the useful work, i.
e. the work spent to move towards the target, rather
than the total work, as a work-related measure of motor
impairment in patients with stroke. In our opinion, the
Worktot did not differ between stroke patients and
healthy individuals because it counts the entire work
performed by the subject; with respect to the patients it
takes into account the work done to move the robot in a
curved path, considering both the “physiological part of
the movement” (toward the target) and the “pathological
part of the movement” (perpendicular to the correct
direction). Therefore, it is combined by two factors, one
reducing because of the impairment, and one increasing
because of the impairment. This could also affect the
correlations with the clinical scales.
A limitation of this study is the absence of robotic
measurement assessing movement smoothness. In fact,
movement smoothness, quantified by means of several
parameters based on velocity or more commonly jerk,
was found to be an hallmark of severity in patients with
stroke [37]. It is worth noting that, almost the totality of
the studies obtained these parameters after a data reduc-
tion, starting from the raw data provided by the robot.
MOTORE, as well as providing the investigated parame-
ters, allow the access to raw data, and, therefore, allow
to compute smoothness parameter. Obviously, this is
more time-consuming, and likely, more suitable for use
in research rather than in clinical practice. Since this
study is especially designed to assess the properties of
the provided robotic indices for a routine clinical use,
we decided not to consider indices computed from raw
data. In fact, the goal of this study is to use these mea-
sures to obtain a frequent evaluation during the treat-
ment, with the aim of calibrating the treatment on
patient’s needs, ability, and motor changes, in order to
design patient-tailored rehabilitation programs. Future
work should be addressed to analyze the properties of
the measure of smoothness, obtained from raw data.
Finally, the design of this study is cross-sectional. A
longitudinal design is needed to measure responsiveness
of the robotic parameters after rehabilitation.
Conclusion
We found that all the robotic indices but the Worktot
provided by a novel robotic device for the upper limb
rehabilitation, are reliable, sensitive and strongly corre-
lated both with motor and disability clinical scales.
Therefore, they are suitable as an evaluation tool for the
upper limb motor performance of patients with sub-
acute stroke in clinical practice. The instrumental
outcome measures are very important to have an object-
ive but also easy evaluation, as well as to define the best
treatment for the patient. In fact, the recovery of the
upper limb can vary greatly from patient to patient and
in this perspective, instrumental and objective data could
be a guide to address the treatment path.
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